Status:
COMPLETED
Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study)
Lead Sponsor:
California Retina Consultants
Conditions:
Age-related Macular Degeneration
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the efficacy and comfort of two FDA approved pre-injection antiseptics when used for intravitreal injections.
Detailed Description
Intravitreal injection of medicine has become the most common ocular procedure billed to Medicare. One of the main problems with this procedure is the postoperative discomfort due to the need to disin...
Eligibility Criteria
Inclusion
- Subjects must be receiving same day bilateral injections of an anti-VEGF agent for any ophthalmic condition.
- Subject must be fluent in English.
Exclusion
- Under 18 years old.
- Subjects with an allergy or adverse reaction to Povidone Iodine or Avenova.
Key Trial Info
Start Date :
July 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04018482
Start Date
July 16 2019
End Date
August 14 2019
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
California Retina Consultants
Santa Barbara, California, United States, 93103